314 related articles for article (PubMed ID: 30139738)
41. A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma.
Stirnweiss A; McCarthy K; Oommen J; Crook ML; Hardy K; Kees UR; Wilton SD; Anazodo A; Beesley AH
Oncogenesis; 2015 Nov; 4(11):e174. PubMed ID: 26551281
[TBL] [Abstract][Full Text] [Related]
42. Challenges and Opportunities in NUT Carcinoma Research.
Hakun MC; Gu B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562801
[TBL] [Abstract][Full Text] [Related]
43. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.
Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H
Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466
[TBL] [Abstract][Full Text] [Related]
44. NUT midline carcinoma: an aggressive intrathoracic neoplasm.
Parikh SA; French CA; Costello BA; Marks RS; Dronca RS; Nerby CL; Roden AC; Peddareddigari VG; Hilton J; Shapiro GI; Molina JR
J Thorac Oncol; 2013 Oct; 8(10):1335-8. PubMed ID: 24457244
[TBL] [Abstract][Full Text] [Related]
45. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.
Chen M; Yang J; Lv L; Li Y; Tang Y; Liu W; Wang W; Jiang L
Hum Pathol; 2021 Sep; 115():56-66. PubMed ID: 33713695
[TBL] [Abstract][Full Text] [Related]
47. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
[TBL] [Abstract][Full Text] [Related]
48. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.
Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM
J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633
[TBL] [Abstract][Full Text] [Related]
49. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19).
French CA; Miyoshi I; Aster JC; Kubonishi I; Kroll TG; Dal Cin P; Vargas SO; Perez-Atayde AR; Fletcher JA
Am J Pathol; 2001 Dec; 159(6):1987-92. PubMed ID: 11733348
[TBL] [Abstract][Full Text] [Related]
50. The importance of diagnosing NUT midline carcinoma.
French CA
Head Neck Pathol; 2013 Mar; 7(1):11-6. PubMed ID: 23463074
[TBL] [Abstract][Full Text] [Related]
51. Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.
Yan J; Diaz J; Jiao J; Wang R; You J
J Biol Chem; 2011 Aug; 286(31):27663-75. PubMed ID: 21652721
[TBL] [Abstract][Full Text] [Related]
52. Pathogenesis of NUT midline carcinoma.
French CA
Annu Rev Pathol; 2012; 7():247-65. PubMed ID: 22017582
[TBL] [Abstract][Full Text] [Related]
53. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
[No Abstract] [Full Text] [Related]
54. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
55. NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V; Saluja K; Pina-Oviedo S
Front Oncol; 2022; 12():860830. PubMed ID: 35372003
[TBL] [Abstract][Full Text] [Related]
56. Uncommon somatic mutations in metastatic NUT midline carcinoma.
Cavalieri S; Stathis A; Fabbri A; Sonzogni A; Perrone F; Tamborini E; Pelosi G; de Braud F; Platania M
Tumori; 2017 Nov; 103(Suppl. 1):e5-e8. PubMed ID: 28967088
[TBL] [Abstract][Full Text] [Related]
57. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M
BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442
[TBL] [Abstract][Full Text] [Related]
58. Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro.
Haruki N; Kawaguchi KS; Eichenberger S; Massion PP; Gonzalez A; Gazdar AF; Minna JD; Carbone DP; Dang TP
J Med Genet; 2005 Jul; 42(7):558-64. PubMed ID: 15994877
[TBL] [Abstract][Full Text] [Related]
59. The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns.
Zee BM; Dibona AB; Alekseyenko AA; French CA; Kuroda MI
PLoS One; 2016; 11(10):e0163820. PubMed ID: 27698495
[TBL] [Abstract][Full Text] [Related]
60. BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.
Nelson BA; Lee EY; French CA; Bauer DE; Vargas SO
J Thorac Imaging; 2010 Aug; 25(3):W93-6. PubMed ID: 20395873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
